Logo image of MDLZ

MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

USA - NASDAQ:MDLZ - US6092071058 - Common Stock

57.18 USD
+0.99 (+1.76%)
Last: 11/7/2025, 8:00:01 PM
57.01 USD
-0.17 (-0.3%)
After Hours: 11/7/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MDLZ. MDLZ was compared to 87 industry peers in the Food Products industry. MDLZ has an excellent profitability rating, but there are concerns on its financial health. MDLZ is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year MDLZ was profitable.
MDLZ had a positive operating cash flow in the past year.
Each year in the past 5 years MDLZ has been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

Looking at the Return On Assets, with a value of 4.95%, MDLZ is in the better half of the industry, outperforming 71.26% of the companies in the same industry.
The Return On Equity of MDLZ (13.49%) is better than 80.46% of its industry peers.
With a decent Return On Invested Capital value of 6.25%, MDLZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 7.83%. This is significantly below the industry average of 28.25%.
Industry RankSector Rank
ROA 4.95%
ROE 13.49%
ROIC 6.25%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

Looking at the Profit Margin, with a value of 9.38%, MDLZ belongs to the top of the industry, outperforming 85.06% of the companies in the same industry.
MDLZ's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 11.59%, MDLZ is in the better half of the industry, outperforming 77.01% of the companies in the same industry.
In the last couple of years the Operating Margin of MDLZ has grown nicely.
With a decent Gross Margin value of 31.05%, MDLZ is doing good in the industry, outperforming 72.41% of the companies in the same industry.
MDLZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.59%
PM (TTM) 9.38%
GM 31.05%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
The number of shares outstanding for MDLZ has been reduced compared to 1 year ago.
Compared to 5 years ago, MDLZ has less shares outstanding
The debt/assets ratio for MDLZ has been reduced compared to a year ago.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MDLZ has an Altman-Z score of 2.27. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.27, MDLZ perfoms like the industry average, outperforming 56.32% of the companies in the same industry.
The Debt to FCF ratio of MDLZ is 9.31, which is on the high side as it means it would take MDLZ, 9.31 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 9.31, MDLZ is doing good in the industry, outperforming 62.07% of the companies in the same industry.
A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a worse Debt to Equity ratio (0.76) than 62.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 9.31
Altman-Z 2.27
ROIC/WACC0.84
WACC7.44%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Current ratio of 0.61 is on the low side compared to the rest of the industry. MDLZ is outperformed by 88.51% of its industry peers.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
With a Quick ratio value of 0.37, MDLZ is not doing good in the industry: 82.76% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.37
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for MDLZ have decreased strongly by -21.70% in the last year.
The Earnings Per Share has been growing slightly by 6.91% on average over the past years.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 4.13% in the last year.
Measured over the past years, MDLZ shows a small growth in Revenue. The Revenue has been growing by 7.09% on average per year.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%

3.2 Future

MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.92% yearly.
MDLZ is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.83% yearly.
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.06, MDLZ is valued on the expensive side.
MDLZ's Price/Earnings is on the same level as the industry average.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.83.
The Price/Forward Earnings ratio is 17.50, which indicates a rather expensive current valuation of MDLZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 65.52% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 32.68, MDLZ is valued a bit cheaper.
Industry RankSector Rank
PE 20.06
Fwd PE 17.5
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MDLZ.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
Industry RankSector Rank
P/FCF 32.31
EV/EBITDA 15.79
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.9
EPS Next 2Y-2.67%
EPS Next 3Y0.99%

6

5. Dividend

5.1 Amount

MDLZ has a Yearly Dividend Yield of 3.57%. Purely for dividend investing, there may be better candidates out there.
MDLZ's Dividend Yield is a higher than the industry average which is at 5.19.
Compared to an average S&P500 Dividend Yield of 2.39, MDLZ pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.57%

5.2 History

On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

MDLZ pays out 69.92% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (11/7/2025, 8:00:01 PM)

After market: 57.01 -0.17 (-0.3%)

57.18

+0.99 (+1.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-28 2025-10-28/amc
Earnings (Next)02-02 2026-02-02/amc
Inst Owners88.19%
Inst Owner Change-0.57%
Ins Owners0.14%
Ins Owner Change0.32%
Market Cap73.99B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts75.88
Price Target72.78 (27.28%)
Short Float %1.88%
Short Ratio3.55
Dividend
Industry RankSector Rank
Dividend Yield 3.57%
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date09-30 2025-09-30 (0.5)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-3%
PT rev (3m)-1.12%
EPS NQ rev (1m)0.36%
EPS NQ rev (3m)5.58%
EPS NY rev (1m)-0.22%
EPS NY rev (3m)0.06%
Revenue NQ rev (1m)-0.55%
Revenue NQ rev (3m)0.46%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 20.06
Fwd PE 17.5
P/S 1.97
P/FCF 32.31
P/OCF 20.69
P/B 2.83
P/tB N/A
EV/EBITDA 15.79
EPS(TTM)2.85
EY4.98%
EPS(NY)3.27
Fwd EY5.72%
FCF(TTM)1.77
FCFY3.1%
OCF(TTM)2.76
OCFY4.83%
SpS29.09
BVpS20.23
TBVpS-13.67
PEG (NY)N/A
PEG (5Y)2.9
Graham Number36.02
Profitability
Industry RankSector Rank
ROA 4.95%
ROE 13.49%
ROCE 8.75%
ROIC 6.25%
ROICexc 6.42%
ROICexgc 45.17%
OM 11.59%
PM (TTM) 9.38%
GM 31.05%
FCFM 6.08%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 9.31
Debt/EBITDA 3.47
Cap/Depr 96.19%
Cap/Sales 3.42%
Interest Coverage 250
Cash Conversion 62.74%
Profit Quality 64.85%
Current Ratio 0.61
Quick Ratio 0.37
Altman-Z 2.27
F-Score5
WACC7.44%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-13.39%
EPS Next 2Y-2.67%
EPS Next 3Y0.99%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year5.04%
Revenue Next 2Y4.57%
Revenue Next 3Y4.25%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year11.05%
EBIT Next 3Y8.25%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%

MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


What is the valuation status for MDLZ stock?

ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.


What is the profitability of MDLZ stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.


What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?

The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 20.06 and the Price/Book (PB) ratio is 2.83.


How financially healthy is MONDELEZ INTERNATIONAL INC-A?

The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.